GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » LT-Debt-to-Total-Asset

CurveBeam AI (ASX:CVB) LT-Debt-to-Total-Asset : 0.23 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. CurveBeam AI's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.23.

CurveBeam AI's long-term debt to total assets ratio increased from Dec. 2023 (0.19) to Dec. 2024 (0.23). It may suggest that CurveBeam AI is progressively becoming more dependent on debt to grow their business.


CurveBeam AI LT-Debt-to-Total-Asset Historical Data

The historical data trend for CurveBeam AI's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI LT-Debt-to-Total-Asset Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23 Jun24
LT-Debt-to-Total-Asset
- - 0.22 0.23

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23 Jun24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial - 0.22 0.19 0.23 0.23

CurveBeam AI LT-Debt-to-Total-Asset Calculation

CurveBeam AI's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

LT Debt to Total Assets (A: Jun. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Jun. 2024 )/Total Assets (A: Jun. 2024 )
=14.558/63.329
=0.23

CurveBeam AI's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=15.264/66.707
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI  (ASX:CVB) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


CurveBeam AI LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the company's CT devices to assist in the clinical assessment. The company has one operating segment, being the research, design, manufacture and sale of cone beam CT imaging equipment for orthopaedic specialties, which includes the development, validation and preparation for commercialisation of a HRpQCT Medical Device and Software as a Service (SaaS) platform.

CurveBeam AI Headlines

No Headlines